Protecting UK adolescents and adults against meningococcal serogroup B disease

Informa UK Limited - Tập 17 Số 3 - Trang 229-237 - 2018
Andrew Vyse1, Gillian Ellsbury1, Harish Madhava1
1Vaccine Medical Affairs, Pfizer Limited, Walton Oaks, Surrey, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1586/eri.13.42

10.1016/j.jadohealth.2016.04.012

10.1080/14760584.2017.1258308

10.1586/14760584.2015.1071670

10.1016/j.vaccine.2015.06.046

10.1080/14760584.2017.1308828

10.1016/j.vaccine.2015.05.101

10.1016/j.vaccine.2013.03.034

10.1136/bmj.g5725

10.1016/j.vaccine.2016.11.076

10.1586/14760584.2016.1130628

Public Health England. [Cited 2017 Aug 7]. Available from: https://www.gov.uk/government/organisations/public-health-england.

ECDC. Surveillance of invasive bacterial diseases in Europe. 2015. [cited 2017 Aug 7] available at https://ecdc.europa.eu/en.

10.1016/j.jinf.2016.07.016

10.1016/S1473-3099(15)00217-0

10.1016/S1474-4422(12)70180-1

10.1371/journal.pone.0177082

10.1016/j.vaccine.2015.05.073

10.1586/14787210.2015.1070096

10.1016/j.jinf.2017.05.015

10.1586/erv.11.117

10.1016/j.vaccine.2017.03.007

10.1016/j.vaccine.2012.03.011

Public Health England. Invasive meningococcal B infections laboratory reports in England by capsular group and epidemiological year, 1998/99–2015/16 [cited 2017 Aug 7]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/563521/Table_1_Invasive_meningococcal_infections_lab_reports__England_by_capsular_group___epi_year.pdf.

10.1016/S0140-6736(16)31921-3

10.1136/archdischild-2015-308928

Public Health England. Invasive meningococcal B infections laboratory reports in England by age group and epidemiological year, 1998/99–2016/17 [cited 2018 Jan 11]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/563526/Table_4_Invasive_meningococcal_B_infections_lab_reports__England_by_age_group___epi_year.pdf.

10.1017/S0950268805005339

10.1586/erv.09.48

10.1080/21645515.2015.1080400

10.1016/S1473-3099(10)70251-6

10.1586/eri.11.89

10.3201/eid1206.051297

10.1016/j.jinf.2015.02.006

10.1136/bmj.320.7238.846

Ala’Aldeen D, 2000, J Clin Micro, 38, 2311, 10.1128/JCM.38.6.2311-2316.2000

10.3201/eid2306.161768

10.1093/pubmed/fdv015

10.1016/j.vaccine.2008.05.073

10.1007/s10096-013-1897-6

10.1016/j.vaccine.2015.06.011

10.1007/s40273-013-0057-2

10.1086/504804

10.2807/esm.11.07.00635-en

10.1016/S1473-3099(11)70027-5

10.1586/14760584.2015.1004317

10.1016/j.vaccine.2017.05.065

10.2807/1560-7917.ES2014.19.44.20949

10.1001/jama.281.20.1906

10.1017/S0950268899002368

10.1017/S0950268801005301

10.1136/bmj.38725.728472.BE

10.1016/j.vaccine.2017.09.024

10.1002/phar.1790

10.1093/cid/cit243

10.15585/mmwr.mm6441a3

10.1542/peds.2016-1890

10.1016/j.tmaid.2009.07.001

10.1016/j.ijid.2012.03.011

10.1136/bmj.325.7360.365

10.1128/CVI.00314-12

10.1016/j.vaccine.2017.03.027

10.1016/j.ijid.2015.11.014

10.2807/1560-7917.ES.2016.21.45.30395

10.2807/1560-7917.ES.2016.21.45.30392

10.1186/s12916-015-0538-6

10.1371/journal.pone.0175024

Immunisation of individuals with underlying medical conditions [cited 2018 Jan 11]. www.gov.uk/government/uploads/system/uploads/attachment_data/file/566853/Green_Book_Chapter7.pdf .

10.1093/cid/cix438

10.1016/j.vaccine.2015.05.073

Bland M, 2009, N Z Med J, 11, 30

Dubé E, 2015, Can J Infect Dis Med Microbiol, 26, 163, 10.1155/2015/732464

10.1016/S1473-3099(16)30377-2

10.1080/21645515.2017.1381810

10.3201/eid2206.151093